Tempest Therapeutics, Inc. has exercised an option under its agreement with Hebei Senlang Biotechnology Co., Ltd. to obtain an exclusive...
-
-
Recent Updates
- At China’s big import fair, sellers try to crack a tough market
- Hang Seng Opens Down 0.8% While Shanghai Edges Higher
- Tempest Takes China-Linked CAR-T License After Early Multiple Myeloma Data
- China Spy Allegation Draws Nvidia CEO Jensen Huang and Alice Huang Into Tech Scrutiny
- Jensen Huang Affair Raises China Spy Concerns in Taiwan Chip Sector
- NVIDIA Faces China Scrutiny as Jensen Huang Succession Risk Moves to Center Stage
- Germany Bans China-Made Drones From Military Training Over Beijing Data Fears
- Chinese Supplier Hints at Apple’s Rumored AI Glasses and Camera AirPods
- Chinese University With Military Ties Obtained Nvidia AI Chips Despite U.S. Blacklist
- Singapore Address Raises Questions in Nvidia Chip Inquiry Linked to China
Blogroll